¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"lateral phase separation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • lateral sinus
    °¡Âʱ¼, ¿ÜÃøµ¿
  • lateral spinothalamic tract
    °¡ÂÊô¼ö½Ã»ó·Î, ¿Ü̫̿¼ö½Ã»ó·Î
  • lateral sulcus
    °¡Âʰí¶û, ¿ÜÃø±¸
  • lateral sural cutaneous nerve
    °¡ÂÊÀåµýÁöÇǺνŰæ, ¿ÜÃøºñº¹ÇǽŰæ
  • lateral surface
    °¡Âʸé, ¿ÜÃø¸é, Ãø¸é
  • lateral venous lacuna
    °¡ÂÊÁ¤¸ÆÁÖ¸Ó´Ï
  • lateral ventricle
    °¡Âʳú½Ç, Ãø³ú½Ç
  • lateral view
    Ãø¸é¿µ»ó
  • primary lateral sclerosis
    ¿ø¹ß°¡ÂʰæÈ­Áõ, ¿ø¹ßÃø»è°æÈ­Áõ
  • retrograde lateral plantar artery flap
    ¿ªÇà°¡Âʹ߹ٴڵ¿¸ÆÇÇÆÇ, ¿ªÇà¿ÜÃøÁ·Àúµ¿¸ÆÇÇÆÇ
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â
  • active phase
    Ȱ¼º±â
  • acute phase reactant
    ±Þ¼º±â¹ÝÀÀ¹°Áú
  • acute phase reaction
    ±Þ¼º±â¹ÝÀÀ
  • acute phase serum
    ±Þ¼º±âÇ÷û
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • lateral nasal prominence
    °¡ÂÊÄÚÀ¶±â
  • lateral oblique position
    ¿·ºñ½ºµë´©¿òÀÚ¼¼
  • lateral orbital sulcus
    °¡ÂÊ´«È®°í¶û
  • lateral plantar nerve
    °¡Âʹ߹ٴڽŰæ
  • lateral plate mesoderm
    °¡ÂÊÆÇÁ߹迱
  • lateral recumbent position
    ¿·´©¿òÀÚ¼¼, Ãø¿ÍÀ§
  • lateral spinothalamic tract
    °¡ÂÊô¼ö½Ã»ó·Î
  • lateral sural cutaneous nerve
    °¡ÂÊÀåµýÁöÇǺνŰæ
  • lateral venous lacuna
    °¡ÂÊÁ¤¸Æ°ø°£
  • primary lateral sclerosis
    ¿ø¹ß°¡ÂʰæÈ­Áõ
  • 3D phase contrast angiography
    »ïÂ÷¿øÀ§»ó´ëÁ¶Ç÷°üÁ¶¿µ¼ú
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â
  • acute phase reactant
    ±Þ¼º±â¹ÝÀÀ¹°Áú
  • acute phase reaction
    ±Þ¼º±â¹ÝÀÀ
  • acute phase serum
    ±Þ¼º±âÇ÷û
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • acute phase serum
    ±Þ¼ºº´±âÇ÷û
  • acute phase substances
    ±Þ¼º±â ¹°Áú(ÐáàõÑ¢Úªòõ).
  • advanced sleep phase syndrome
    ÀüÁø¼º ¼ö¸éÀ§»ó ÁõÈıº
  • anal-sadistic phase
    Ç×¹®-°¡ÇÐ(½Ã)±â
  • arterial phase
    µ¿¸Æ±â
  • full erection phase
    ¿ÏÀü¹ß±â±â
  • g0 phase
    Á¤Áö±â G0±â
  • g1 phase
    ÇÕ¼ºÀü±â G1±â
  • g2 phase
    ÇÕ¼ºÈıâ G2±â
  • gastric phase
    À§»ó(êÖßÓ) À§»êºÐºñ(êÖߤÝÂÝô)ÀÇ .
  • go phase
    Á¤Áö±â Go±â
  • gradient induced phase shift effect
    °æ»ç À¯µµ À§»ó º¯À§ È¿°ú
  • grinding phase
    ºÐ¼â»ó.
  • implantational phase
    Âø»ó±â
  • in-phase image
    À§»ó³» ¿µ»ó
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • bilateral phase
    ´ëαâ
  • bulk phase model
    µ¢¾î¸® À§»ó ¸ðÇü
  • cephalic phase
    ³ú»ó(ÒàßÓ)
  • circadian-phase intervention
    ÀÏÁÖ±â-»ó ÁßÀç(ìíñÎÑ¢-ßÓ ñêî®)
  • colostral phase
    ÃÊÀ¯±â
  • compression phase
    ¾ÐÃà»ó
  • death phase
    »ç¸ê±â
  • delayed sleep phase
    Áö¿¬¼º ¼ö¸é»ó(òÀæÅàõ â²ØùßÓ)
  • delayed sleep phase syndrome
    Áö¿¬¼º ¼ö¸é»ó ÁõÈıº(òÀæÅàõ â²ØùßÓ ñøý¦ÏØ)
  • depressive phase
    ¿ì¿ï»ó(éØê¦ßÓ)
  • diastolic phase
    È®Àå±â(üªíåÑ¢).
  • diplotene phase
    °ã¼¶À¯±â
  • diurnal phase
    ÁÖ°£»ó(ñÎÊàßÓ)
  • ejection phase
    ¹ÚÃâ±â(ÚÑõóÑ¢).
  • ejection phase
    ¹ÚÃâ±â.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Lateral branches
    °¡Âʰ¡Áö
    [¿¾ ¿ë¾î] ¿ÜÃøÁö
  • Lateral angle
    °¡Âʰ¢
    [¿¾ ¿ë¾î] ¿ÜÃø°¢
  • Lateral head
    °¡Âʰ¥·¡
    [¿¾ ¿ë¾î] ¿ÜÃøµÎ
  • Lateral costotransverse ligament
    °¡Âʰ¥ºñ°¡·Îµ¹±âÀδë
    [¿¾ ¿ë¾î] ¿ÜÃø´ÁȾµ¹±âÀδë
  • Lateral tubercle
    °¡ÂʰáÀý
    [¿¾ ¿ë¾î] ¿ÜÃø°áÀý
  • Lateral collateral ligament
    °¡ÂʰçÀδë
    [¿¾ ¿ë¾î] ¿ÜÃøÃøºÎÀδë
  • Lateral sulcus
    °¡Âʰí¶û
    [¿¾ ¿ë¾î] ¿ÜÃø±¸
  • Lateral atlanto-occipital ligament
    °¡ÂÊ°í¸®µÚÅë¼öÀδë
    [¿¾ ¿ë¾î] ¿ÜÃøÈ¯ÃßÈĵÎÀδë
  • Lateral atlanto-axial joint
    °¡ÂÊ°í¸®Áß¼è°üÀý
    [¿¾ ¿ë¾î] ¿ÜÃøÈ¯Ãà°üÀý
  • Lateral habenular nucleus
    °¡Âʰí»ßÇÙ
    [¿¾ ¿ë¾î] ¿ÜÃø°í»ßÇÙ
  • Lateral proper fasciculus
    °¡ÂʰíÀ¯´Ù¹ß
    [¿¾ ¿ë¾î] Ãø°íÀ¯¼Ó
  • Lateral rectus muscle
    °¡ÂʰðÀº±Ù
    [¿¾ ¿ë¾î] ¿ÜÃøÁ÷±Ù
  • Lateral condyle
    °¡ÂʰüÀýÀ¶±â
    [¿¾ ¿ë¾î] ¿ÜÃø°ú
  • Lateral supracondylar ridge
    °¡ÂʰüÀýÀ¶±âÀ§´É¼±
    [¿¾ ¿ë¾î] ¿ÜÃø°ú»ó¸ª
  • Lateral supracondylar line
    °¡ÂʰüÀýÀ¶±âÀ§¼±
    [¿¾ ¿ë¾î] ¿ÜÃø°ú»ó¼±
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • phase contrast
    À§»ó´ëÁ¶
  • phase contrast MR angiography
    À§»ó´ëÁ¶ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ¼ú
  • phase curve
    À§»ó°î¼±
  • phase display
    À§»óÇ¥½Ã
  • phase encode direction
    À§»óºÎȣȭ¹æÇâ
  • phase encoding
    À§»óºÎȣȭ
  • phase encoding gradient
    À§»óºÎȣȭ°æ»çµµ(Àå)
  • phase encoding step
    À§»óºÎÈ£´Ü°è
  • phase evolution of fat suppression
    À§»ó¼±È¸ Áö¹æ¾ïÁ¦
  • phase frequency swap
    À§»óÁ֯ļö±³È¯
  • phase image
    À§»ó¿µ»ó
  • phase mismapping
    À§»ó¿ÀÁöµµÀÛ¼º
  • phase offset multiplannar [=POMP] imaging
    À§»ó¿ÀÇÁ¼Â´Ù¸é¿µ»ó
  • phase sensitive technique description
    À§»ó¹Î°¨¹ý¼³¸í
  • phase shift
    À§»óº¯À§
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
LVN lateral ventricular nerve; lateral vestibular nucleus; Licensed Visiting Nurse; Licensed Vocational ...
LPD Luteal Phase Defect
AP accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p...
APP acute phase protein; alum-precipitated pyridine; aminopyrazolopyrimidine; amyloid peptide precursor;...
APR abdominoperineal resection; absolute proximal reabsorption; acute phase reaction or reactant; amebic...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
HS-SPME Headspace solid phase microextraction
ISRP Internal surface reversed-phase
LLPDD Late Luteal Phase Dysphoric Disorder
LPR Late phase response
LPD Luteal phase defect
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • phase ratio
    »óºñ
  • phase shift
    À§»ó º¯À§
  • phase shift effect
    À§»ó º¯À§ È¿°ú
  • phase wrap
    À§»ó Æ÷Àå
  • phase wraparound artifact
    À§»ó Æ÷Àå Àΰø¹°
  • portal phase
    ¹®¸Æ±â
  • preeruptive phase
    ¸ÍÃâÀü ´Ü°è
  • prefunctional eruptive phase
    ±â´ÉÀü ¸ÍÃ⠴ܰè
  • premenstrual :

    premenstrual phase

    ¿ù°æ Àü±â
    ¿ù°æÀÌ °³½ÃÇÏ´Â Á÷Àü ½Ã±â.
  • prodromal vasoconstriction phase
    Àü±¸¼º Ç÷°ü ¼öÃà±â
  • proliferation phase
    Áõ½Ä±â
  • respiratory ordered phase encoding
    È£Èí ¼øÀ§ »ó ºÎȣȭ
  • rising phase
    »ó½Â±â
  • S phase
    S ±â
    Á¤Áö±â, °íÁ¤»ó. ¼¼±Õ ¹è¾ç¿¡ À־ ¼¼±ÕÀÇ Áõ½ÄÀÌ ¼­¼­È÷ ÁÙ¾îµé¾î ¼¼±Õ ¼ö°¡ °ÅÀÇ ÀÏÁ¤ÇÑ ¼ö·Î º¸ÀüµÇ´Â ½Ã±â.
  • sleep phase advance
    ¼ö¸é À§»ó ÀüÁø
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
phase I clinical trial <pharmacology> The earliest stage clinical trial for studying an experimental drug in humans. Phase I trials are generally comparatively small and are used to determine toxicity and maximum dose.
They provide an initial evaluation of a drug's safety and pharmacokinetics-how the drug is absorbed, what tissues it reaches and how long it takes to leave the body. Such studies also usually test various doses of the drug (dose-ranging) to obtain an indication of the appropriate dose to use in later studies.
The patients in these trials usually have advanced disease and have already received best available chemotherapy, therefore, seeing a repose is significant partially because this means there is a lack of cross-resistance between two anti-cancer drugs.
(31 Dec 1997)
phase II block Inhibition of nerve impulse transmission across the myoneural junction unaccompanied by depolarisation of the motor endplate, as in the muscle paralysis produced by tubocurarine.
(05 Mar 2000)
phase II clinical trial <pharmacology> Usually focus on the activity of the new product as a single agent in a noncomparative, open study.
(31 Dec 1997)
phase III clinical trial <pharmacology> An advanced stage clinical trial that should conclusively show how well a drug works as compared to other treatments.
Phase III trials are large, frequently multi-institution tests. They generally compare the relative value of the new drug compared with the current standard treatment and measure whether a new drug extends survival or otherwise improves the health of patients on treatment (clinical improvement) rather than just provide surrogate marker data. These studies generally last longer and are larger than phase II trials.
(31 Dec 1997)
phase image A magnetic resonance image showing only phase shift information, to detect motion.
(05 Mar 2000)
phase plate <microscopy> The plate used near the back focal plane of a microscope objective lens (in conjunction with an annulus at the front focal plane of the condenser lens) to achieve phase contrast. The phase plate selectively shifts the phase of the waves diffracted by the specimen by a quarter wave and reduces the amplitude of the undeviated, direct beam.
(05 Aug 1998)
phase, resting More appropriately called interphase. The interval in the cell cycle between two cell divisions when the individual chromosomes cannot be distinguished, interphase was once thought to be the resting phase but it is far from a time of rest for the cell. It is the time when DNA is replicated in the cell nucleus.
(12 Dec 1998)
phase rule An expression of the relationships existing between systems in equilibrium: P + V = C + 2, where P is the number of phases, V the variance or degrees of freedom, and C the number of components; it also follows that the variance is, V = C + 2 -P. For H2O at its triple point, V = 1 + 2 -3 = 0, i.e., both temperature and pressure are fixed.
Synonym: Gibb's phase rule.
(05 Mar 2000)
phase shift <microscopy> A change in the phase relationship between two alternating quantities of the same frequency.
(05 Aug 1998)
phase variation <microbiology> Alteration in the expression of surface antigens by bacteria.
For example: Salmonella can express either of two forms of flagellin, H1 and H2, that are coded by different genes. Control of which form is expressed is brought about by inversion of the promoter for the H2 gene, which if functional (noninverted) is associated with the expression of H2 and the production of a repressor of the H1 gene.
Inversion occurs about every 1000 bacterial divisions and is under the control of another gene, hin, that is within the invertable sequence.
(31 Dec 1997)
chronic phase Refers to the early stages of chronic myelogenous leukaemia. The number of immature, abnormal white blood cells in the bone marrow and blood is higher than normal, but lower than in the accelerated or blast phase.
(12 Dec 1998)
microscopy, phase-contrast A form of interference microscopy in which variations of the refracting index in the object are converted into variations of intensity in the image. This is achieved by the action of a phase plate.
(12 Dec 1998)
clinical trial, phase I A pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques based on a small number of healthy persons and conducted over the period of about a year in either the united states or a foreign country.
(12 Dec 1998)
clinical trial, phase II A pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques based on several hundred volunteers, including a limited number of patients, and conducted over a period of about two years in either the united states or a foreign country.
(12 Dec 1998)
clinical trial, phase III A pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques after phase II trials. A large enough group of patients is studied and closely monitored by physicians for adverse response to long-term exposure, over a period of about three years in either the united states or a foreign country.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á